First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy‐associated plasma protein A, free‐β human chorionic gonadotrophin, placental growth factor, and α‐fetoprotein

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0223|35|7|709-716

ISSN： 0197-3851

Source： PRENATAL DIAGNOSIS, Vol.35, Iss.7, 2015-07, pp. : 709-716

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of a shift in nuchal translucency measurements on the detection rate of first‐trimester Down syndrome screening: A population‐based study

By  

PRENATAL DIAGNOSIS, Vol. 38, Iss. 2, 2018-01 ,pp. : 106-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated second‐trimester maternal serum β‐human chorionic gonadotropin and amniotic fluid alpha‐fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 12, 2015-12 ,pp. : 1891-1898

John Wiley & Sons Inc

Access to resources Recommend Favorite

First trimester Down syndrome screening: Distribution of markers and comparison of assays for quantification of pregnancy‐associated plasma protein‐A

By Wøjdemann K. R.   Larsen S. O.   Rode L.   Shalmi A.   Sundberg K.   Christiansen M.   Tabor A.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 66, Iss. 2, 2006-04 ,pp. : 101-112

Informa Healthcare

Access to resources Recommend Favorite

Dried blood spot measurement of pregnancy‐associated plasma protein A (PAPP‐A) and free β‐subunit of human chorionic gonadotropin (β‐hCG) from a low‐resource setting

By  

PRENATAL DIAGNOSIS, Vol. 35, Iss. 6, 2015-06 ,pp. : 592-597

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive procedures

By  

PRENATAL DIAGNOSIS, Vol. 35, Iss. 8, 2015-08 ,pp. : 789-796

John Wiley & Sons Inc

Access to resources Recommend Favorite